Monte Rosa Therapeutics' stock traded on the Nasdaq exchange, and the company disclosed transactions with the SEC, including an insider sale on June 24th.
4 reports, 2 independent
Updated Jul 3
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Monte Rosa Therapeutics' stock traded on the Nasdaq exchange, and the company disclosed transactions with the SEC, including an insider sale on June 24th.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Monte Rosa Therapeutics officially listed its shares on the Nasdaq exchange.1 source
- Monte Rosa Therapeutics filed transactions via SEC Form 4 on June 29, involving Chief Medical Officer Filip Janku.Sub-event
Monte Rosa Therapeutics stock traded on Nasdaq; company filed with SEC regarding transactions and insider sales.1 source
Keep exploring
The entities involved
-
Monte Rosa Therapeutics
biotechnology company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
SEC
Slovak company
Related events
- Allient stock traded on NASDAQ and filed required disclosures with the SEC on August 18, 2026.
- Chicago Atlantic Real Estate Finance stock traded on the electronic stock exchange and insider transactions were filed with the SEC on September 4, 2026.
- Burning Rock Biotech Limited listed its stock on the Nasdaq exchange and made insider trading filings with the SEC.
- Royal Bank of Canada increased its stock holdings in Option Care Health, Inc., which trades on the Nasdaq exchange, and the company filed disclosures with the SEC.
- Astera Labs disclosed insider transactions via SEC filings while trading on the Nasdaq stock exchange.